Cell growth requires the synthesis of essential biomolecules, such as nucleo tides and amino acids. The 1C unit supplied by the 1C cycle is one of the basic building blocks to make such molecules. This unit mainly comes from enzymatic cleavage of serine into formaldehyde, which then reacts with tetrahydrofolate (THF)-the active form of folate (vitamin B9) 1 . Diverse chemical transitions process this single carbon unit into various forms, such as formate, which are used eventually in biosynthetic reactions. 1C metabolism is important for human health since folic acid deficiency causes birth defects, nerve damage and anaemia. Deleting key enzymes in the 1C cycle causes embryonic lethality in mice. Furthermore, many cancers overexpress enzymes involved in the 1C cycle, ultimately increasing the flux of 1C units 2 . However, 1C metabolism might also produce formaldehyde, an endogenous protein and DNA crosslinking agent generated by various processes, such as enzymatic demethylation of histones and nucleic acids 3 . Recently, we showed that a two-tier protection mechanism shields mice against endogenous formaldehyde 4 . This mechanism consists of the enzyme alcohol dehydrogenase 5 (ADH5), which removes formaldehyde (tier one), and DNA crosslink repair by the Fanconi anaemia pathway, which reverses DNA damage caused by formaldehyde (tier two). Inactivation of this protection mechanism in mice causes death because endogenous DNA damage leads to multiple organ failure. Here we identify an unexpected route by which the 1C cycle produces formaldehyde. Furthermore, we show that detoxification of endogenous formaldehyde generates a 1C unit that is able to sustain essential metabolism.
Tetrahydrofolate is intrinsically genotoxic
Blood formaldehyde concentrations in humans range between 20 and 100 μ M [5] [6] [7] . These relatively high levels suggest that formaldehyde is produced from a widespread source, such as 1C metabolism. More specifically, the 1C unit is mostly derived from the cleavage of serine by the enzymes serine hydroxymethyltransferase 1 and 2 (SHMT1 and SHMT2), which generates glycine and transiently liberates formaldehyde 1 . However, this formaldehyde quickly reacts with THF to create 5,10-methylene-THF (5,10-me-THF), which is prone to dissociation in vitro to release formaldehyde 8 (Fig. 1a) . THF and 5,10-me-THF are ubiquitous metabolites and can reach concentrations of up to 20 μ M in certain tissues 9, 10 . Therefore, if 5,10-me-THF dissociated to some extent in vivo, it could generate a substantial amount of formaldehyde.
To test this, we assessed the possible genotoxicity of THF supplementation, which should promote the production of 5,10-me-THF 11 . THF exposure induced a DNA damage response in wild-type, Δ ADH5 (tier one deficient) and Δ FANCC (tier two deficient) chicken DT40 cells. This was demonstrated by the induction of FANCD2 monoubiquitination and CHK1 phosphorylation, known DNA damage response markers (Extended Data Fig. 1a) . Additionally, THF exposure was cytotoxic, especially in Δ ADH5, Δ FANCC and other Fanconi anaemia core-complex-deficient cells (Fig. 1b and Extended Data Fig. 1b) . Other tier two protection-defective mutants were also sensitive to THF, including those deficient in the tumour-suppressor genes BRCA1 and BRCA2 (Extended Data Fig. 1c, d) . Consistently, the human B cell line NALM-6 carrying genetic disruptions of FANCB (tier two deficient) or ADH5 showed similar sensitivity to THF (Extended Data Fig. 2a-c) .
In primary mouse cells, combined deficiency of tier one (Adh5 
Fancd2
-/-mice accumulate endogenous DNA damage that leads to liver, kidney and bone marrow failure 4 . Moreover, in DT40 cells, inactivation of two-tier protection is lethal 12 . We therefore tested if this protection mechanism also protected primary bone marrow-derived cells against THF. Indeed, LPS-activated splenic B cells obtained from Adh5
-/-mice were hypersensitive to THF (Fig. 1c) . Moreover, THF was particularly cytotoxic to haematopoietic stem and progenitor
The folate-driven one-carbon (1C) cycle is a fundamental metabolic hub in cells that enables the synthesis of nucleotides and amino acids and epigenetic modifications. This cycle might also release formaldehyde, a potent protein and DNA crosslinking agent that organisms produce in substantial quantities. Here we show that supplementation with tetrahydrofolate, the essential cofactor of this cycle, and other oxidation-prone folate derivatives kills human, mouse and chicken cells that cannot detoxify formaldehyde or that lack DNA crosslink repair. Notably, formaldehyde is generated from oxidative decomposition of the folate backbone. Furthermore, we find that formaldehyde detoxification in human cells generates formate, and thereby promotes nucleotide synthesis. This supply of 1C units is sufficient to sustain the growth of cells that are unable to use serine, which is the predominant source of 1C units. These findings identify an unexpected source of formaldehyde and, more generally, indicate that the detoxification of this ubiquitous endogenous genotoxin creates a benign 1C unit that can sustain essential metabolism.
Article reSeArcH cells (colony-forming unit-spleen (CFU-S)) from Adh5
+/-
Fancd2
-/-mice ( Fig. 1d) . Finally, THF toxicity was suppressed by addition of β-mercaptoethanol (β -ME), which quenches formaldehyde yielding inert 2-((hydroxymethyl)thio)ethanol 12 (Extended Data Fig. 1e ). Increasing THF availability could increase the production of 5,10-me-THF, which then might release formaldehyde. To test this, we used the human haploid cell line HAP1. Consistently, HAP1 Δ ADH5 cells were hypersensitive to THF and this was suppressed by β -ME (Extended Data Fig. 2d ). We then used CRISPR-Cas9 to generate a panel of 1C-cycle-defective knockouts in both wild-type and Δ ADH5 strains (Extended Data Figs 3a and 4a). Such manipulations should limit or abolish the ability of THF to promote the generation of formaldehyde by the route described in Fig. 1a . Although the 1C cycle is essential for cell growth and viability, supplementation with glycine and the nucleotide precursors hypoxanthine and thymidine (HT) can bypass this dependence [13] [14] [15] [16] . Knockout cell lines were verified by sequencing, and protein expression when possible (Extended Data Fig. 4b, c) . For functional validation, each strain was tested for growth in various drop-out media lacking some or most supplements. In addition, these strains were metabolically verified by incubation with [U- 13 C]serine and tracing of the labelled carbon into glycine, ATP and excreted formate 17 (Extended Data Fig. 3b, c) . First, we disrupted the mitochondrial folate pathway by deleting SHMT2 or the mitochondrial folate transporter (MFT, also known as SLC25A32) (Extended Data Fig. 3a-c) . As expected, both mutants had a significant defect in the synthesis of glycine, formate and nucleotides 14, 15 . Inactivation of these genes in Δ ADH5 cells did not suppress THF toxicity (Extended Data Fig. 3d, e) . Next, we inactivated SHMT1, which generates 5,10-me-THF in the cytosol (Extended Data  Fig. 3a-c) . Δ SHMT1 cells proficiently synthesized glycine, formate and nucleotides, indicating that in HAP1 the role of SHMT1 in the 1C cycle is insignificant when the mitochondrial folate pathway is functional. However, deleting SHMT1 in Δ MFT cells led to a more severe defect in the 1C cycle (Extended Data Fig. 3b, c) . Surprisingly, this double disruption did not suppress THF toxicity in ADH5-deficient cells (Extended Data Fig. 3f ). Finally, we decided to further inhibit the 1C cycle by inactivating the enzyme folylpolyglutamate synthase (FPGS), which polyglutamates THF and thereby activates it. Without FPGS, THF is inactive and hence the entire 1C cycle is substantially impeded 16 ( Fig. 1e) . Consequently, Δ FPGS cells were not able to grow in the absence of glycine or HT, even when supplemented with formate or THF. Moreover, Δ FPGS cells were unable to generate glycine, ATP and formate from [U- 13 C]serine (Fig. 1e, f) . However, this disruption did not suppress the sensitivity of Δ ADH5 cells to THF, indicating that THF toxicity is not only independent of the formation of 5,10-me-THF, but also of the entire flux through the 1C cycle (Fig. 1g ). This suggests that THF genotoxicity is intrinsic to THF since it can be dissociated from its role in the 1C cycle.
THF decomposition releases formaldehyde
THF is susceptible to oxidative degradation, which releases its constituents: a pterine moiety and p-aminobenzoylglutamate (pABG). Importantly, a methylene bridge connects these two components, which may be converted to formaldehyde during this process 18 ( Fig. 2a) . To test this hypothesis, we used a highly specific, cell-permeable fluorescent formaldehyde probe (FAP-1) 19 . Both formaldehyde and THF activated this probe in vitro in a concentration-dependent manner ( Fig. 2b and Extended Data Fig. 5a ). Notably, THF releases half of the total formaldehyde in only around 45 min (Fig. 2c) . Ascorbate (vitamin C) is a potent antioxidant and, unlike β -ME, does not quench formaldehyde , formaldehyde generation from THF was supressed at 4 °C and enhanced at 55 °C and 85 °C (Extended Data Fig. 5c ). Moreover, THF also decomposed into formaldehyde in THF-exposed cells, and this was also suppressed by ascorbate (Extended Data Fig. 5d , e). These data indicate that oxidative THF decomposition releases formaldehyde under physiological conditions.
As THF moves through the 1C cycle, it undergoes numerous chemical transitions generating other folate derivatives. Their oxidation propensity has been characterized in vitro: DHF, THF and 5,10-me-THF are oxidation-prone, whereas folate, 5-methyl-THF and 5-formyl-THF are resistant 18, 20 (Fig. 2d) . Indeed, we found that only oxidation-prone derivatives release formaldehyde, both in vitro and in a cellular context. These results were corroborated by gas chromatographymass spectrometry ( Fig. 2e and Extended Data Fig. 5f-h) . Consistently, the cytotoxic potency of folate derivatives mirrored their susceptibility to decomposition (Fig. 2f and Extended Data Fig. 6 ). Cumulatively, these results indicate that decomposition of THF and other folate derivatives releases genotoxic formaldehyde.
ADH5 fuels the growth of 1C-cycle-deficient cells
ADH5 detoxifies formaldehyde, hence protecting the cell against this genotoxin. Formaldehyde reacts spontaneously with glutathione (GSH) to yield S-hydroxymethylglutathione (HMGSH) (Fig. 3a) ; this reaction is predicted to occur efficiently given the high intracellular GSH concentrations (Extended Data Fig. 7a ). Subsequently, ADH5 with NAD(P) + oxidizes HMGSH to create S-formylglutathione (FGSH). The action of S-formylglutathione hydrolase (FGH) regenerates GSH to yield formate 21, 22 (Fig. 3a) . This biochemical route could therefore provide a cell with utilizable 1C units coupled to formaldehyde detoxification. Indeed, we noticed that deleting ADH5 exacerbated the growth defect of 1C-cycle-deficient strains in media lacking nucleotide precursors (without HT; Fig. 3b and Extended Data Fig. 7b ): Δ SHMT2 compared to Δ ADH5;Δ SHMT2 (48% versus 23% cell growth relative to same lines grown with HT); Δ MFT compared to Δ ADH5;Δ MFT (31% versus 17%); and finally Δ MFT;Δ SHMT1 compared to Δ ADH5; c-e, Growth curves of HAP1 1C-cycle-defective strains grown without HT (with Gly). Data are from≥2 independent experiments (six replicates). At least two independent clones were used for all the ADH5-complemented strains. All data represent mean ± s.e.m. Statistical significance was assessed using two-tailed Student's t-tests. ***P ≤ 0.001; **** P ≤ 0.0001.
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Δ MFT;Δ SHMT1 (6% versus 0.5%). These differences were completely suppressed by HT supplementation. To establish further that ADH5 supports the residual growth of 1C-cycle-deficient strains, we examined their growth rates in more detail. Consistently, all 1C-cycle-deficient cell lines were significantly more growth-defective if they also lacked ADH5, with Δ ADH5;Δ MFT;Δ SHMT1 cells showing the most severe defect ( 
Formaldehyde is a meaningful source of 1C units
The most likely reason for ADH5 enabling the growth of 1C-cycledeficient mutants is the conversion of endogenous formaldehyde into formate. These mutant cells should then be auxotrophic for formaldehyde in medium without HT. Notably, addition of 200 μ M formaldehyde to medium without HT restored the normal growth of Δ MFT cells and significantly rescued the growth defect of Δ MFT; Δ SHMT1 cells (Fig. 4a, b ). This formaldehyde auxotrophy was completely dependent on ADH5, since 200 μ M formaldehyde was genotoxic to ADH5-deficient strains (Fig. 4a, b and Extended Data Fig. 9a ). To test whether this formaldehyde auxotrophy is truly due to the ability of ADH5 to process formaldehyde into a useable 1C unit, we incubated cells with formaldehyde concentrations that were not cytotoxic to ADH5-deficient strains ( A key question is whether ADH5 provides a physiologically meaningful route to supply 1C units. Support that it does comes from our observation that, in the absence of formaldehyde supplementation, ADH5 supports growth of HAP1 cells deficient in serine catabolism. Another approach is to define how effectively 1C-cycle-proficient cells use this ADH5 route to supply 1C units when exposed to physiological concentrations of formaldehyde. To do this, we traced 13 C-labelled formaldehyde into excreted formate (Fig. 4d) . The net contribution of formate derived from a given concentration of exogenous formaldehyde can then be compared to that originating from the cellular utilization of natural serine. We compared wild-type with Δ ADH5 strains from several cell lines (HAP1, DT40, NALM-6 and transformed mouse embryonic fibroblasts (tMEFs)) exposed to 20 or 40 μ M [
13 C]formaldehyde ( Fig. 4d and Extended Data Fig. 10a , b). [ 13 C]formaldehyde clearly contributed to the overall formate production (up to around 40% in HAP1 cells), which was completely dependent on ADH5. We also performed the same experiment using primary cells from wild-type and Adh5 -/-mice. In both LPS-activated splenic B cells and primary MEFs, the supply of formate from [ 13 C]formaldehyde was substantial and ADH5-dependent ( Fig. 4d and Extended Data Fig. 10c ). Finally, we assessed whether the ADH5-dependent production of formate contributes to the blood formate concentration. Indeed, mean plasma formate levels in Adh5 -/-mice are reduced by approximately 20% compared to wild-type mice (Fig. 4e) . By contrast, we did not find significant differences in the levels of other 1C-cycle metabolites such as serine, a major source of plasma formate 17 (Extended Data Fig. 10d ). Altogether, these experiments provide strong evidence that ADH5-dependent formaldehyde detoxification can meaningfully contribute to the supply of 1C units in vitro and in vivo. (n = 11) mice. All data represent mean ± s.e.m. Statistical significance was assessed using two-tailed Student's t-tests. * P ≤ 0.05; NS, not significant.
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Formaldehyde supports nucleotide synthesis
A key prediction of our studies is that ADH5-dependent formaldehyde oxidation into formate should provide 1C units that enable nucleotide synthesis 23 . Indeed, [ 13 C]formaldehyde could be traced through to DNA deoxyadenosine (dA) by liquid chromatography-mass spectrometry in HAP1 cells (Fig. 5a, b) . As expected, in Δ MFT cells this incorporation was enhanced, since these cells lack mitochondrial formate synthesis. Tracing lower [ 13 C]formaldehyde into dA is also ADH5-dependent ( Fig. 5c and Extended Data Fig. 11a ). Exposure to these physiological concentrations of [
13 C]formaldehyde also led to significant dA labelling in 1C-cycleproficient cells (Fig. 5d) . Importantly, ADH5-deficient cells were equally effective at incorporating [ 13 C]formate into dA, and concurrent exposure to 40 μ M formaldehyde did not prevent this incorporation (Extended Data Fig. 11b ). This indicates that this dose of formaldehyde does not compromise the usage of formate for nucleotide synthesis in ADH5-deficient cells.
Formaldehyde incorporation should not be restricted to purines, since 1C units are also used to make the pyrimidine thymine (Extended Data Fig. 11c ). Indeed, [ 13 C]formaldehyde could also be traced into DNA thymidine (dT), although the incorporation into this nucleoside was reduced compared with dA (Extended Data Fig. 11d-f ). Tracing Fig. 5f and Extended Data Fig. 11h, i) . In all instances, [ 13 C]formaldehyde contributed significantly to ATP synthesis in an ADH5-dependent manner. Remarkably, in LPS-activated splenic B cells and primary MEFs this accounted for as much as 50% of de novo synthesized ATP. In conclusion, these experiments show that formaldehyde detoxification by ADH5 supplies 1C units that contribute to nucleotide synthesis.
Discussion
Serine is the major source of formate in cells, contributing to around 50% of total formate production in mice 13, 17 . The origin of the remaining 50% is unclear, however a significant fraction could come from endo genous formaldehyde. Notably, the reversal of 1C-unit-derived methylation from DNA, RNA and histones releases formaldehyde 3 , and its detoxification would also provide formate that re-enters 1C metabolism. Based on this circuitous route for formaldehyde-derived (Fig. 5g) . Folate derivatives are constantly decomposing in our bodies [24] [25] [26] , and our findings predict a proportion of this turnover would release formaldehyde. Depleted folate pools may contribute to the genesis of neural tube anomalies. More generally, folic acid deficiency results in widespread health consequences, and this is why the vitamin is a common dietary supplement. However, excess folate consumption can cause developmental abnormalities in mice 27, 28 . While the formaldehyde produced from excessive folic acid consumption would be efficiently dealt with by two-tier protection, some damage may still occur and explain these reported toxic effects. Individuals who lack tier two protection against formaldehyde, such as those afflicted by Fanconi anaemia, might be susceptible to formaldehyde released from folate decomposition. Moreover, a common inherited human mutation is the 677C> T mutation in the gene encoding methylenetetrahydrofolate reductase (MTHFR), which converts 5,10-me-THF to 5-methyl-THF. This mutation may increase folate decomposition 29 , which may explain to some extent why humans carrying the 677C> T mutation might be more prone to certain chronic illnesses.
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The 1C cycle is now understood to have a central role in the remodelled metabolism of cancer cells 2 . The enzymes that drive remodelled 1C metabolic circuits are therefore promising therapeutic targets. However, our work shows that cancer cells could resupply their 1C needs through formaldehyde detoxification. Finally, some effective chemotherapeutic agents that block aspects of 1C metabolism are useful in cancer treatment but they also kill normal cells 30 . We now suggest a new strategy to target certain cancer cells, particularly those deficient in DNA crosslink repair such as BRCA1-or BRCA2-mutant cancers. Delivering a source of formaldehyde in the form of folate derivatives in combination with ADH5 inhibition could selectively kill such cancer cells.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
MethOdS
Cell culture and cytotoxicity assays. All chemicals/reagents were purchased from Sigma, unless otherwise stated. DT40 cells 12 were grown in RPMI medium (Gibco) supplemented with 3% chicken serum (Gibco), 7% fetal calf serum (Gibco), 50 μ M β -mercaptoethanol and penicillin/streptomycin (Gibco). NALM-6 cells were grown in RPMI medium supplemented with 10% fetal calf serum, 50 μ M β -mercaptoethanol and penicillin/streptomycin. FANCB-deficient NALM-6 cells were a gift 31 . HAP1 cells (Haplogen) were grown in IMDM medium (Gibco) supplemented with 10% dialysed fetal calf serum and penicillin/streptomycin. Transformed MEFs and primary MEFs were grown in DMEM medium (Gibco) supplemented with 10% dialysed fetal calf serum and penicillin/streptomycin. LPS-blasted spleen B cells were grown in RPMI medium supplemented with 10% fetal calf serum, 50 μ M β -mercaptoethanol, penicillin/streptomycin and 40 μ g ml
LPS. All cell lines and primary cells were grown at 37 °C and 5% CO 2 . All cell lines used in the study were tested to be mycoplasma-free. DT40 and NALM-6 cell lines were not authenticated.
For cytotoxicity assays, 5 × 10 3 cells (DT40 and NALM-6) or 2.5 × 10 3 cells (HAP1) were plated in a 96-well plate in triplicate for each condition. The indicated amounts of formaldehyde (Thermo Fisher Scientific), tetrahydrofolate and other folate derivatives (Schircks Laboratories) were added to these wells on the day of plating (DT40 and NALM-6) or 24 h after plating (HAP1). Cell viability was measured using MTS reagent (Promega) 3 days (DT40), 4 days (HAP1) or 5 days (NALM-6) after plating. Absorbance at 492 nm was measured with a Pherastar spectrophotometer. THF sensitivity of HAP1 1C-cycle-deficient mutants was determined with three independent targeted clones.
Mice. Adh5
-/-
Fancd2
-/-mice, Adh5
-/-mice and controls were from a C57BL/6 × 129SV hybrid background and were generated as described previously 4 .
Mice from a C57BL/6 pure background were used for the measurement of metabolites in plasma, generation of MEFs and tracing of [ To trace [ 13 C]formaldehyde into formate and ATP, cells were grown in the presence of LPS for 48 h before the addition of the tracer. Generation of mouse embryonic fibroblasts (MEFs). Generation of MEFs has been described elsewhere 32 . Transformation of these cells was performed by retroviral transduction with large T antigen (pBABE-SV40 LT, Addgene). CFU-S assays. CFU-S assays were performed as reported previously 33 . Supplementary Table 1 . Each guide sequence was cloned into pX458 or pX461 vectors 34 . NALM-6 Δ ADH5 clones were generated using both approaches (pX458 and pX461). NALM-6 cells were transfected with the CRISPR plasmids using the Amaxa Nucleofector Kit T (Lonza) according to the manufacturer's protocol. Generation and validation of HAP1 Δ ADH5 cells has been shown before 35 . For targeting of 1C cycle genes, cells were transfected with Turbofectin 8.0 (Origene). Two days post-transfection, GFP-positive cells were single-cell sorted into 96-well plates containing medium supplemented with 20% fetal calf serum, using a MoFlo cell sorter (BeckmanCoulter). After 14 days of incubation at 37 °C, individual clones were analysed for expression of the relevant protein by western blotting. Targeted loci were subjected to Sanger sequencing (GATC). Supplementary Table 2 5 cells were transfected in 6-well plates with 2 μ g of plox-ADH5-2×Flag-BSR using 6 μ g polyethylenimine as a transfection reagent. Two days after transfection, 20 μ g ml −1 blasticidin (Gibco) was added, and after 10 days of selection complemented clones were single-cell sorted into 96-well plates containing medium supplemented with 20% fetal calf serum and 20 μ g ml −1 blasticidin, using a MoFlo cell sorter (Beckman-Coulter).
CRISPR-Cas9-mediated gene disruptions in NALM-6 and HAP1 cells. Guide sequences for each gene targeting can be found in
After 14 days, individual clones were analysed for ADH5 expression by western blotting. To further assess ADH5 complementation, the positive clones were tested for resistance against formaldehyde. Western blotting. Cells were lysed for 30 min on ice in RIPA buffer (Thermo Fisher Scientific), including protease inhibitor cocktail (Roche) and phosphatase inhibitor cocktail (Roche). For the detection of FANCD2 in DT40 cells, samples were run on a 3-8% Tris-Acetate gel (Thermo Fisher Scientific). Samples were blotted to a 0.45 μ m nitrocellulose membrane. Protein samples were run on a 4-12% Bis-Tris gel (Thermo Fisher Scientific) to detect phosphorylated CHK1 (Ser345) and β -actin in DT40 cells and ADH5, SHMT1, SHMT2 and β -actin in HAP1 cells. Antibodies can be found in Supplementary Table 3 .
Growth assays with HAP1 cells in the presence or absence of various supplements. Growth in drop-out media: HAP1 cells (3.4 × 10 3 ) were plated 6 times in a 96-well plate in medium without glycine supplemented with glycine and hypoxanthine and thymidine (HT); HT only; glycine only; glycine and formate or THF. Six days later, cell growth was assayed by MTS. Growth was expressed as percentage of cell growth relative to the same cells grown with glycine and HT or relative to wild-type cells grown with glycine and HT. In Fig. 3b , three independent clones were used for all 1C-cycle-deficient strains.
Formaldehyde or THF supplementation: the same amounts of cells were plated in triplicate in two 96-well plates per cell line in medium without HT. Six hours later, formaldehyde or THF was added, with or without HT supplement, to one plate. For the next five days, cells were given a new dose of formaldehyde or THF that was 1.5× the preceding dose. Each indicated dose is the total, cumulative dose of each compound, given to the cells during those 6 days of treatment. After these 6 days, cell growth was assayed by MTS. Growth was expressed as percentage of cell growth relative to the same cells grown with HT.
Growth curves of HAP1 cells. HAP1 cells (6.8 × 10
3 per well, 6 wells in total) were plated (with or without HT) in a 96-well plate on day 0 (one plate for each time point). After 4 h, the cell growth was measured using MTS reagent as described above (day 0). At each indicated day, cell growth was measured using MTS again with one of the remaining plates. Each data point indicates the cell growth of that day relative to day 0 and is the average of at least two independent experiments. At least two independent clones were used for each ADH5-complemented strain.
Crystal-violet-stained plates of 1C-cycle-deficient HAP1 cells. Growth in media with or without HT: 4 × 10
5 cells were plated in 6-well plates and grown in each medium. When cells proficient for ADH5 were close to confluence, cells were washed with PBS and stained in 6% glutaraldehyde and 0.5% crystal violet. An exception is ΔMFT;ΔSHMT1 and ΔADH5;ΔMFT;ΔSHMT1 cells grown in medium without HT; 4 × 10 6 cells were plated and stained after 6 days. Growth in medium without HT supplemented with formaldehyde, THF or formate: 4 × 10 5 cells were plated in 6-well plates. For five days after plating, cells were treated with a dose formaldehyde or THF each day. Each consecutive dose was 1.5 × the preceding dose. Each indicated dose is the total, cumulative dose of each compound, given to the cells during 5 days. Formate was given in a single dose on day 1 of treatment. Six days after plating, cells were stained as described above. Formaldehyde detection with FAP-1. Formaldehyde was detected with FAP-1, a formaldehyde-specific fluorescent probe 19 . For the in vitro analysis, formaldehyde, THF or other folate derivatives were mixed with FAP-1 (10 μ M) in PBS (pH 7.4) in a 96-well plate. Fluorescence (λ ex = 640 nm, λ em = 680 nm) was measured at t = 0 and t = 30 min with a Pherastar spectrophotometer (software version 5.30 R3) or an emission spectrum (λ ex = 645 nm) was obtained between λ em = 655-750 nm with a Cary Eclipse fluorometer (Varian, Advance Reads Application software version 1.1). Fluorescence increase (between t = 0 and t = 30 min) was calculated and corrected for the untreated control. A formaldehyde standard curve was used to calculate the concentration of formaldehyde. To measure the release of formaldehyde by different folate derivatives, these molecules were incubated in PBS at 37 °C for 24 h before addition of FAP-1. To monitor the release of formaldehyde by THF over time under different conditions, an aliquot was taken at each time point, mixed with 1% sodium ascorbate and placed on ice to stop the oxidative degradation. FAP-1 was then added to all samples and the fluorescence was measured. Different formaldehyde standards were used for each condition, treated in the same manner. These were used to create a formaldehyde standard curve at each time point for each condition, which was used to determine the concentration of formaldehyde.
For the cellular analysis of formaldehyde release, HAP1 cells were maintained in medium without phenol red (Gibco). One million cells were resuspended in BSS buffer (136.9 mM NaCl, 5.37 mM KCl, 1.26 mM CaCl 2 , 0.81 mM MgSO 4 , 0.44 mM KH 2 PO 4 , 0.335 mM Na 2 HPO 4 , 10 mM PIPES, set to pH 7.2 with NaOH) including 5 μ M FAP-1 and incubated for 30 min at 37 °C. Cells were then washed with BSS and resuspended in 1 ml BSS supplemented with formaldehyde or a folate derivative with or without sodium ascorbate. The fluorescence was measured in the R-670
Article reSeArcH channel of a Fortessa flow cytometer (BD Biosciences, model number 647788E1) after two hours. At least 13,000 cells were measured per sample. The data were acquired using BDFACSDiva Software 6.2 and analysed with FlowJo 10.0.7 (Tree Star). The gating strategy is shown in Supplementary Fig. 2 . In brief, intact cells were gated using SSC-A and FSC-A. Of this population, single cells were selected using FSC-A and FSC-H. Of all single cells, the geometric mean of R-670-A fluorescent signal was calculated. Measurements were corrected for autofluorescence by subtracting the geometric mean of the fluorescence from the unstained control.
Formaldehyde detection by gas chromatography-mass spectrometry (GC-MS).
To measure the release of formaldehyde by different folate derivatives, these molecules were incubated in PBS at 37 °C for 24 h. After incubation, cyclohexanone (internal standard) was added to each sample at a final concentration of 1 mg l −1
. GC-MS analysis was carried out using an Agilent 7890A GC and 5975C MS with CTC-PAL autosampler (Agilent Technologies). A DB-WAX capillary column (l = 30 m, I.D. = 0.25 mm, dF = 0.25 μ m from Agilent Technologies) was used for the analysis. Samples were analysed by on-fibre derivatization, solid phase micro extraction (SPME). A 65 μ m PDMS/DVB fibre was pre-exposed to the headspace of a solution of 8 mg ml −1 O-(2,3,4,5,6-pentafluorobenzyl)hydroxylamine (PFBHA) in water (HPLC grade, VWR) for 10 min at room temperature, samples were incubated at 35 °C for 10 min and then the PFBHA coated fibres were exposed to the sample headspace for 25 min at 35 °C for analyte extraction and derivatization. Fibre desorption in the GC inlet was then carried out for 7 min. The GC oven conditions were as follows: the initial column temperature was 30 °C, which was held for 4 min then raised to 250 °C at 12 °C per min, where it was held for 2 min, giving a total run time of 24.33 min. The split/splitless inlet temperature was maintained at 250 °C and the septum purged at 2 ml per min. The GC inlet was operated in split mode (10:1) with 1 ml per min column flow rate using helium (N6.0 grade, BOC) as a carrier gas.
The mass spectrometer was operated in single ion monitoring mode for the ions m/z 181, 195 and 225 for formaldehyde-PFBHA oxime (retention time 11.47 min) and m/z 181, 195 and 293 for cyclohexanone-PFBHA oxime internal standard (retention time 16.73 min) with m/z 181 used for quantification for both compounds. A dwell time of 200 ms was used for each ion. The transfer line to the mass spectrometer was heated to 220 °C, the source temperature was maintained at 230 °C and the quadrupole at 150 °C. The GC-MS data were acquired using MassHunter GCMS Acquisition B.07.05.2479.
For quantification, all analyte integrated peak areas were ratioed to internal standard areas using MassHunter Quantitative Analysis Version B.07.01 SP1/Build 7.1.524.1 for GCMS. The method was calibrated across the range of 0.1 to 5 mg l medium) by GC-MS, extraction of intracellular metabolites and determination of labelled and non-labelled glycine, ATP and glutathione by LC-MS were performed as described previously 17 . All data were corrected for natural abundance of 13 C. In all the tracing experiments, dialysed fetal calf serum was used.
Analysis of plasma formate was performed as described previously 17 . For the analysis of serine, glycine and methionine in plasma, frozen plasma samples were thawed on ice and 5 μ l of sample was transferred to a microcentrifuge tube, diluted with 245 μ l ice-cold extraction fluid (as described previously 17 ) and shaken for 10 min at 4 °C and 1,200 r.p.m. After centrifugation (10 min at 18,213g and 4 °C) the supernatant was transferred to LC vials and kept at − 75 °C before LC-MS analysis.
The measurement and data analysis of the metabolites using TraceFinder 3.1 (Thermo Fisher Scientific) were done according to previous work 17 . GC-MS data were acquired and analysed using MassHunter Workstation Software Quantitative Analysis Version B.06.00/Build 6.0.388.0 (Agilent Technologies). Analysis of metabolites in plasma was performed blinded. Calculation of 13 C incorporation into de novo synthesized ATP. To calculate the 13 C incorporation into de novo synthesized ATP from [ 13 C]formaldehyde, the ATP mass fractions were first corrected for the natural isotope abundance. The remaining M+ 1 and M+ 2 fractions are a result of incorporation of 13 C from [ 13 C]formaldehyde at the two 1C units in ATP. Assuming that both carbons can be labelled with equal probability p, the ATP M+ 1 and M+ 2 fractions are modelled by the equations
, respectively, where P 0 , P 1 and P 2 are the ATP M+ 0, 1 and 2 fractions, respectively. Solving these equations for p we obtain p = 2P 2 /(P 1 + 2P 2 ). The reported 13 C enrichment in the 1C units of ATP was obtained using the latter equation and the measured P 1 and P 2 . Statistical analysis. All measurements were taken from distinct samples, unless otherwise stated. All data represent mean ± s.e.m. Statistical significance was assessed using two-tailed Student's t-test (* P ≤ 0.05; * * P ≤ 0.01; * * * P ≤ 0.001; * * * * P ≤ 0.0001; NS, not significant). No statistical methods were used to predetermine sample size. Unless otherwise stated, the experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. Data availability. Source Data are provided for animal experiments (Fig. 1,  Fig. 4 and Extended Data Fig. 10 ). Any additional information required to interpret, replicate or build upon the Methods or findings reported in the manuscript is available upon request from the corresponding author. Uncropped scans can be seen in Supplementary Fig. 1 . Bottom, cellular sensitivity assays showing that resistance to formaldehyde is restored in the ADH5-complemented strains. Data are from two independent experiments carried out in triplicate. At least two independent clones were used for all the ADH5-complemented strains. d-f, Growth curves in medium with HT of HAP1 1C-cycle-defective strains proficient, deficient (ΔADH5) or complemented (ΔADH5 + ADH5-Flag) for ADH5 expression. Data are from at least two independent experiments, each with six replicates. At least two independent clones were used for all the ADH5-complemented strains. All data represent mean ± s.e.m. -/-(n = 11) mice. The plasma samples tested are the same as those shown in Fig. 4e . All data represent mean ± s.e.m. Statistical significance was assessed using two-tailed Student's t-tests. NS, not significant. 
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Data exclusions
Describe any data exclusions.
No data was excluded from the analyses.
Replication
Describe whether the experimental findings were reliably reproduced.
All attempts at replication were successful.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Randomization is not relevant for our studies as our experiments are genetically controlled.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Blinding was used for the analysis of metabolites in plasma and CFU-S quantification.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
